title: [Genetic testing, prevention and health care insurance markets].
abstract: Since this special issue of medecine/sciences is devoted to personalized medicine, it seems unnecessary for two economists to summarize or discuss, from a medical perspective, recent advances in genetic research. We rather focus on the consequences of improved genetic testing on the health insurance market, on how this market may be affected and on the degree of coverage offered to consumers according to the regulations implemented. More precisely, we first study the value of the information conveyed by genetic tests and we then decompose this value into several components according to the regulations implemented in various health insurance markets.
authors.affiliation: Universidad de Los Andes, Calle 19A n° 1-37 Este - Bloque W - Piso 9, Bogotá, Colombie.
authors.forename: David
authors.initials: D
authors.lastname: Bardey
authors.affiliation: Toulouse school of economics (TSE), CNRS-Gremaq (groupe de recherche en économie mathématique et quantitative), Institut d'économie industrielle (IDEI), MF 102, 21, allée de Brienne, 31000 Toulouse, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: De Donder
mesh_terms: D003219:Confidentiality / Q000331:legislation & jurisprudence; D005820:Genetic Testing / Q000191:economics / Q000331:legislation & jurisprudence; D014943:Global Health; D019981:Health Care Sector; D006297:Health Services Accessibility; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence; D007348:Insurance, Health / Q000331:legislation & jurisprudence; D057285:Precision Medicine; D011315:Preventive Medicine / Q000191:economics / Q000458:organization & administration*; D014342:Truth Disclosure